The University of Chicago Header Logo

Peter H. O'Donnell

Concepts (446)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacogenetics
39
2023
443
12.450
Why?
Pharmacogenomic Testing
14
2022
98
6.560
Why?
Carcinoma, Transitional Cell
21
2024
171
5.930
Why?
Urologic Neoplasms
17
2024
84
4.130
Why?
Precision Medicine
15
2023
410
4.040
Why?
Urinary Bladder Neoplasms
18
2024
401
3.190
Why?
Drug-Related Side Effects and Adverse Reactions
7
2022
203
3.130
Why?
Antineoplastic Agents
23
2024
2415
2.230
Why?
Cisplatin
18
2024
618
2.220
Why?
Pharmacogenomic Variants
4
2021
42
2.220
Why?
Decision Support Systems, Clinical
5
2019
105
1.950
Why?
Perioperative Care
6
2022
170
1.840
Why?
Antibodies, Monoclonal
14
2024
1412
1.790
Why?
Drug Prescriptions
5
2021
144
1.590
Why?
Immunoconjugates
2
2022
113
1.540
Why?
Neoplasms
10
2022
3041
1.480
Why?
Biomarkers, Tumor
7
2022
1549
1.480
Why?
Clinical Decision-Making
5
2021
281
1.460
Why?
Antimetabolites, Antineoplastic
6
2020
244
1.430
Why?
Antibodies, Monoclonal, Humanized
13
2024
969
1.400
Why?
Patient Portals
2
2020
17
1.400
Why?
Humans
118
2024
89357
1.340
Why?
Decision Support Techniques
2
2021
167
1.320
Why?
Prescription Drugs
2
2019
36
1.280
Why?
Anesthesiology
2
2022
162
1.250
Why?
Genotype
11
2023
1849
1.230
Why?
Polymorphism, Single Nucleotide
8
2021
2401
1.210
Why?
Capecitabine
6
2024
98
1.180
Why?
Practice Patterns, Physicians'
5
2021
601
1.090
Why?
Patient Acceptance of Health Care
2
2020
260
1.080
Why?
Aged, 80 and over
27
2024
6811
1.050
Why?
Health Knowledge, Attitudes, Practice
2
2020
533
1.010
Why?
Genomics
5
2022
762
1.000
Why?
Cardiovascular Agents
2
2015
54
0.970
Why?
Middle Aged
47
2024
25974
0.970
Why?
Aged
41
2024
19165
0.950
Why?
Urothelium
5
2023
71
0.930
Why?
Prospective Studies
12
2022
4289
0.930
Why?
Hematopoietic Stem Cell Transplantation
7
2016
890
0.910
Why?
Male
52
2024
42411
0.880
Why?
Point-of-Care Systems
3
2019
148
0.840
Why?
Female
51
2024
46202
0.820
Why?
Tramadol
1
2022
14
0.800
Why?
Antineoplastic Agents, Immunological
4
2020
198
0.790
Why?
Germ-Line Mutation
4
2020
344
0.790
Why?
Kidney Neoplasms
5
2021
638
0.790
Why?
Pain Management
2
2021
138
0.780
Why?
Hepatic Veno-Occlusive Disease
2
2012
19
0.770
Why?
Busulfan
2
2012
41
0.770
Why?
Adult
36
2023
26607
0.750
Why?
Platinum
5
2023
63
0.750
Why?
Anesthetics
1
2021
53
0.750
Why?
B7-H1 Antigen
9
2022
274
0.740
Why?
Rheumatology
1
2021
35
0.730
Why?
Analgesics
1
2021
119
0.720
Why?
Anesthesia
1
2022
170
0.690
Why?
Carcinoma, Renal Cell
3
2021
437
0.670
Why?
Drug Labeling
2
2017
41
0.640
Why?
Information Dissemination
1
2019
114
0.630
Why?
Medication Adherence
1
2020
140
0.630
Why?
Drug Therapy
2
2018
70
0.620
Why?
Cardiovascular Diseases
2
2015
711
0.620
Why?
Pharmacology, Clinical
1
2018
8
0.620
Why?
Quinazolines
2
2016
221
0.600
Why?
Medical Order Entry Systems
1
2017
25
0.580
Why?
Germ Cells
2
2022
130
0.570
Why?
Follow-Up Studies
11
2022
3666
0.560
Why?
Analgesics, Opioid
1
2021
444
0.560
Why?
Patient Care
1
2018
102
0.560
Why?
Vidarabine
3
2012
143
0.550
Why?
Genome, Human
3
2019
767
0.550
Why?
Receptor, Fibroblast Growth Factor, Type 3
1
2016
25
0.540
Why?
Patient Education as Topic
1
2019
360
0.540
Why?
Fluorouracil
2
2023
561
0.540
Why?
Receptor, ErbB-3
1
2016
20
0.530
Why?
Benzamides
3
2024
237
0.530
Why?
Critical Care
1
2019
382
0.530
Why?
Physician's Role
1
2017
177
0.510
Why?
Clinical Medicine
1
2015
34
0.500
Why?
Cytochrome P-450 CYP2D6
3
2022
52
0.500
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2015
85
0.500
Why?
Collagen Type I
1
2015
72
0.500
Why?
Physician-Patient Relations
2
2019
625
0.500
Why?
Snake Venoms
2
2015
10
0.500
Why?
Clinical Trials, Phase II as Topic
4
2014
172
0.500
Why?
Patient Selection
3
2018
684
0.490
Why?
Academic Medical Centers
2
2015
385
0.490
Why?
Quality of Life
6
2024
1668
0.490
Why?
Programmed Cell Death 1 Receptor
5
2022
171
0.480
Why?
Receptor, ErbB-2
1
2016
246
0.470
Why?
Pyrroles
2
2015
187
0.460
Why?
Genetic Predisposition to Disease
4
2019
2340
0.460
Why?
Transplantation Conditioning
4
2014
374
0.450
Why?
Inflammation
1
2019
972
0.450
Why?
Cardiology
1
2015
115
0.450
Why?
Program Development
1
2014
123
0.440
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
2566
0.440
Why?
Ambulatory Care
2
2014
187
0.440
Why?
Indoles
2
2015
314
0.440
Why?
Neovascularization, Pathologic
1
2015
364
0.430
Why?
Biomarkers, Pharmacological
1
2012
21
0.420
Why?
Hematologic Neoplasms
4
2016
343
0.420
Why?
Nectins
2
2022
9
0.420
Why?
Pain
4
2024
400
0.410
Why?
Stomach Neoplasms
1
2015
282
0.410
Why?
Mutation
6
2020
4143
0.410
Why?
Patient Reported Outcome Measures
3
2024
192
0.410
Why?
Cystectomy
2
2024
110
0.400
Why?
Peptides
1
2015
648
0.390
Why?
Protein Kinase Inhibitors
1
2016
605
0.390
Why?
Pharmaceutical Preparations
1
2012
92
0.380
Why?
Kidney Failure, Chronic
2
2016
414
0.370
Why?
Treatment Outcome
18
2024
8241
0.370
Why?
Neoplasm Staging
7
2021
2018
0.370
Why?
Cell Adhesion Molecules
2
2022
167
0.370
Why?
Prognosis
12
2020
3783
0.370
Why?
Patient Safety
4
2023
218
0.370
Why?
Deoxycytidine
1
2012
238
0.360
Why?
Antibodies, Neoplasm
1
2010
84
0.360
Why?
Drug Delivery Systems
1
2012
179
0.360
Why?
Neoplasm Recurrence, Local
1
2017
1365
0.360
Why?
Hemoglobinopathies
1
2010
10
0.350
Why?
Drug Resistance, Neoplasm
3
2011
618
0.350
Why?
Carcinoma
3
2021
443
0.340
Why?
Neoplasm Metastasis
7
2024
1109
0.340
Why?
Kidney Medulla
1
2010
81
0.340
Why?
Brain Neoplasms
1
2015
782
0.340
Why?
BK Virus
1
2009
23
0.340
Why?
Dose-Response Relationship, Drug
5
2019
1942
0.330
Why?
Polyomavirus Infections
1
2009
28
0.330
Why?
Carboplatin
6
2016
312
0.330
Why?
Hematuria
1
2009
50
0.330
Why?
Tumor Virus Infections
1
2009
81
0.330
Why?
Pyrimidines
3
2018
374
0.320
Why?
Prostatic Neoplasms, Castration-Resistant
2
2024
121
0.320
Why?
Breast Neoplasms
2
2020
3011
0.320
Why?
Warfarin
2
2019
104
0.320
Why?
Genetic Testing
4
2019
537
0.310
Why?
Disease Susceptibility
1
2009
200
0.310
Why?
Genetic Variation
3
2014
1374
0.310
Why?
Anemia, Sickle Cell
1
2010
144
0.290
Why?
Risk Assessment
3
2021
2303
0.290
Why?
Surveys and Questionnaires
3
2020
2624
0.290
Why?
Models, Genetic
1
2012
945
0.280
Why?
Urinary Bladder
3
2024
246
0.280
Why?
Kidney Diseases
1
2009
319
0.270
Why?
Cohort Studies
4
2019
2872
0.270
Why?
Risk Factors
5
2021
5499
0.270
Why?
Genotyping Techniques
2
2018
69
0.260
Why?
Transplantation, Homologous
7
2020
996
0.260
Why?
Sirolimus
1
2006
170
0.260
Why?
Kidney
1
2011
1147
0.250
Why?
Neoplasm Invasiveness
6
2024
576
0.250
Why?
Randomized Controlled Trials as Topic
4
2019
838
0.250
Why?
Neuroendocrine Tumors
1
2006
118
0.240
Why?
Tertiary Care Centers
2
2016
106
0.230
Why?
Phenylthiohydantoin
1
2024
48
0.230
Why?
Polymorphism, Genetic
3
2015
825
0.230
Why?
Medical Oncology
2
2022
383
0.230
Why?
Nitriles
1
2024
160
0.230
Why?
Survival Analysis
6
2023
1534
0.220
Why?
Sleep Initiation and Maintenance Disorders
1
2024
53
0.220
Why?
Angiogenesis Inhibitors
2
2016
317
0.220
Why?
Neutropenia
1
2023
216
0.220
Why?
Alemtuzumab
3
2012
85
0.220
Why?
Receptors, Glucocorticoid
1
2024
131
0.210
Why?
Adenine Nucleotides
2
2014
63
0.210
Why?
Arabinonucleosides
2
2014
39
0.210
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2023
77
0.210
Why?
Hospitalization
2
2019
877
0.210
Why?
Chicago
5
2015
1427
0.210
Why?
Thrombocytopenia
1
2023
187
0.210
Why?
Fenretinide
1
2002
2
0.210
Why?
Omeprazole
1
2022
11
0.200
Why?
Succinylcholine
1
2022
14
0.200
Why?
Ceramides
1
2002
35
0.200
Why?
Hydralazine
1
2022
19
0.200
Why?
Practice Guidelines as Topic
3
2018
1047
0.200
Why?
Young Adult
5
2019
6312
0.200
Why?
Sulfonamides
2
2016
318
0.200
Why?
Oxycodone
1
2022
35
0.200
Why?
Lymphocytes
3
2010
471
0.190
Why?
Muscles
1
2021
193
0.180
Why?
Ferredoxin-NADP Reductase
1
2020
15
0.180
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2020
27
0.180
Why?
Genome-Wide Association Study
7
2012
1671
0.170
Why?
Pyrazines
1
2020
94
0.170
Why?
Research
2
2019
252
0.170
Why?
Disease-Free Survival
6
2021
1214
0.170
Why?
Inpatients
1
2022
310
0.170
Why?
Clinical Trials as Topic
2
2016
1150
0.170
Why?
Drug Recalls
1
2019
13
0.170
Why?
Health Plan Implementation
1
2019
56
0.170
Why?
Codeine
1
2019
12
0.170
Why?
CREB-Binding Protein
1
2018
16
0.160
Why?
Phenotype
3
2019
2440
0.160
Why?
E1A-Associated p300 Protein
1
2018
14
0.160
Why?
Pilot Projects
2
2019
871
0.160
Why?
Survival Rate
3
2018
1901
0.160
Why?
Predictive Value of Tests
2
2021
1723
0.160
Why?
Acute Kidney Injury
2
2014
312
0.160
Why?
Evidence-Based Medicine
1
2021
433
0.160
Why?
Gene Expression Regulation, Neoplastic
3
2021
1265
0.160
Why?
Tumor Microenvironment
2
2022
463
0.160
Why?
Response Evaluation Criteria in Solid Tumors
4
2021
58
0.160
Why?
Tumor Burden
1
2019
308
0.150
Why?
Program Evaluation
1
2019
307
0.150
Why?
Infusions, Intravenous
3
2017
435
0.150
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2002
395
0.150
Why?
United States
5
2017
6989
0.150
Why?
Radiosurgery
1
2021
288
0.150
Why?
Guidelines as Topic
1
2019
160
0.150
Why?
Abdominal Neoplasms
1
2017
39
0.150
Why?
Lymphocytes, Tumor-Infiltrating
1
2018
131
0.140
Why?
Standard of Care
1
2017
65
0.140
Why?
Pain, Postoperative
1
2019
252
0.140
Why?
Health Personnel
1
2019
215
0.140
Why?
Tissue Donors
1
2020
494
0.140
Why?
Disease Management
1
2019
329
0.140
Why?
Organoplatinum Compounds
2
2019
97
0.140
Why?
Drug Therapy, Computer-Assisted
1
2016
8
0.140
Why?
Hospital Mortality
1
2019
387
0.140
Why?
User-Computer Interface
1
2017
187
0.140
Why?
Social Perception
1
2017
95
0.130
Why?
Safety
1
2017
149
0.130
Why?
Anticoagulants
1
2019
427
0.130
Why?
Chemoradiotherapy
1
2018
309
0.130
Why?
Benzodioxoles
1
2015
16
0.130
Why?
Attitude to Health
1
2017
222
0.130
Why?
Immunotherapy
2
2020
682
0.130
Why?
Case-Control Studies
1
2020
1862
0.130
Why?
Universities
2
2013
148
0.130
Why?
Vascular Cell Adhesion Molecule-1
1
2015
56
0.130
Why?
Transcription Factor RelA
1
2015
49
0.130
Why?
5' Untranslated Regions
1
2015
51
0.130
Why?
G(M2) Ganglioside
1
2015
3
0.130
Why?
Tay-Sachs Disease
1
2015
6
0.120
Why?
Communication
1
2019
460
0.120
Why?
Adolescent
7
2023
9263
0.120
Why?
Forecasting
1
2016
306
0.120
Why?
Response Elements
1
2015
65
0.120
Why?
Tunica Intima
1
2015
60
0.120
Why?
Area Under Curve
2
2014
337
0.120
Why?
Fatal Outcome
1
2015
299
0.120
Why?
Ureter
1
2016
93
0.120
Why?
Epilepsies, Myoclonic
1
2015
18
0.120
Why?
Maximum Tolerated Dose
2
2017
272
0.120
Why?
Nomograms
1
2014
29
0.120
Why?
Attitude of Health Personnel
1
2019
645
0.120
Why?
Data Interpretation, Statistical
1
2016
299
0.120
Why?
Kidney Transplantation
2
2016
850
0.120
Why?
CD8-Positive T-Lymphocytes
1
2018
595
0.110
Why?
Exome
1
2014
127
0.110
Why?
Electronic Health Records
1
2017
347
0.110
Why?
Liver Neoplasms
2
2017
758
0.110
Why?
Genetic Markers
1
2014
478
0.110
Why?
Radiography
1
2015
809
0.110
Why?
Total Quality Management
1
2013
33
0.110
Why?
Software
1
2017
665
0.110
Why?
Receptors, Cell Surface
1
2014
289
0.110
Why?
Muscle Neoplasms
1
2013
18
0.110
Why?
Endothelium, Vascular
1
2015
433
0.110
Why?
Endonucleases
1
2012
23
0.110
Why?
Workflow
1
2013
80
0.110
Why?
Fanconi Anemia
1
2012
9
0.110
Why?
Neoadjuvant Therapy
1
2016
377
0.110
Why?
Genetics, Medical
1
2013
52
0.100
Why?
Delivery of Health Care
1
2017
435
0.100
Why?
Databases, Factual
1
2016
856
0.100
Why?
DNA Repair
1
2014
362
0.100
Why?
Lymphocyte Depletion
1
2012
98
0.100
Why?
Models, Statistical
1
2016
576
0.100
Why?
High-Throughput Nucleotide Sequencing
3
2022
481
0.100
Why?
Biopsy
2
2016
1184
0.100
Why?
Biomedical Research
2
2013
398
0.100
Why?
Blood Glucose
1
2016
836
0.100
Why?
Disease Progression
3
2016
1489
0.100
Why?
Atherosclerosis
1
2015
257
0.100
Why?
Combined Modality Therapy
3
2024
1719
0.100
Why?
Time Factors
3
2016
5338
0.100
Why?
Fibroblasts
1
2015
755
0.100
Why?
T-Lymphocytes
2
2022
1224
0.100
Why?
Graft vs Host Disease
2
2012
360
0.100
Why?
Melphalan
1
2011
98
0.100
Why?
Decision Making
1
2017
667
0.100
Why?
HLA Antigens
1
2012
227
0.090
Why?
Population Groups
1
2010
41
0.090
Why?
Metabolic Clearance Rate
1
2010
120
0.090
Why?
Liver
2
2014
1208
0.090
Why?
Stem Cell Transplantation
1
2012
188
0.090
Why?
Chromosomes, Human, X
1
2011
55
0.090
Why?
Population Surveillance
1
2012
216
0.090
Why?
Graft Rejection
2
2016
1070
0.090
Why?
Postoperative Complications
2
2016
2284
0.090
Why?
Inhibitory Concentration 50
1
2010
64
0.090
Why?
Drug Combinations
1
2010
203
0.090
Why?
Cell Line, Transformed
1
2010
155
0.090
Why?
Tumor Suppressor Protein p53
1
2012
414
0.090
Why?
Vinca Alkaloids
1
2009
3
0.090
Why?
Cell Line
5
2011
2496
0.080
Why?
Anthracyclines
1
2009
38
0.080
Why?
Chemotherapy, Adjuvant
1
2011
487
0.080
Why?
Down-Regulation
1
2010
519
0.080
Why?
Antineoplastic Agents, Alkylating
1
2009
138
0.080
Why?
DNA
1
2014
1308
0.080
Why?
Haplotypes
1
2010
637
0.080
Why?
Creatinine
1
2009
293
0.080
Why?
Cell Proliferation
2
2010
1652
0.070
Why?
Genetics, Population
1
2010
406
0.070
Why?
Fatigue
2
2022
179
0.070
Why?
DNA-Binding Proteins
1
2012
1242
0.070
Why?
Diabetes Mellitus
1
2013
742
0.070
Why?
Incidence
1
2010
1595
0.070
Why?
Neurons
1
2015
1584
0.070
Why?
Immunosuppressive Agents
1
2010
975
0.060
Why?
Drug Administration Schedule
2
2017
895
0.060
Why?
Kidney Function Tests
2
2016
114
0.060
Why?
Ovarian Neoplasms
1
2011
764
0.060
Why?
Androgen Receptor Antagonists
1
2024
22
0.060
Why?
Magnetic Resonance Imaging
1
2016
3448
0.060
Why?
Indazoles
2
2016
67
0.060
Why?
Models, Biological
1
2011
1765
0.060
Why?
Receptors, Androgen
1
2024
123
0.060
Why?
Head and Neck Neoplasms
1
2011
1063
0.060
Why?
Hyperparathyroidism
1
2003
67
0.060
Why?
Dihydrouracil Dehydrogenase (NADP)
1
2023
29
0.050
Why?
Parathyroidectomy
1
2003
77
0.050
Why?
Cell Line, Tumor
3
2016
2558
0.050
Why?
Pharmacists
1
2022
33
0.050
Why?
Kaplan-Meier Estimate
2
2018
860
0.050
Why?
Glomerular Filtration Rate
2
2016
275
0.050
Why?
Clinical Trials, Phase I as Topic
2
2014
156
0.050
Why?
Adrenal Insufficiency
1
2022
23
0.050
Why?
Sphingolipids
1
2002
20
0.050
Why?
Alleles
2
2017
1135
0.050
Why?
Vaccines, Synthetic
1
2022
55
0.050
Why?
Morpholines
1
2002
69
0.050
Why?
Reproducibility of Results
2
2021
2758
0.050
Why?
Antibody Formation
1
2022
171
0.050
Why?
Age Factors
2
2020
1870
0.050
Why?
Drug Synergism
1
2002
306
0.050
Why?
Immunity, Cellular
1
2022
178
0.050
Why?
DNA Damage
1
2023
371
0.050
Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
1
2021
53
0.050
Why?
Gene Fusion
1
2021
39
0.050
Why?
Bone Marrow Transplantation
1
2001
283
0.050
Why?
Blood Transfusion
1
2001
169
0.050
Why?
Risk
2
2012
657
0.050
Why?
Antibodies, Viral
1
2022
309
0.050
Why?
Hodgkin Disease
1
2001
181
0.050
Why?
Tumor Cells, Cultured
1
2002
1057
0.040
Why?
Prostatic Neoplasms
1
2011
1769
0.040
Why?
Vaccination
1
2022
274
0.040
Why?
Cell Survival
1
2002
983
0.040
Why?
Protein-Tyrosine Kinases
1
2021
307
0.040
Why?
Double-Blind Method
1
2023
1719
0.040
Why?
Allografts
1
2020
181
0.040
Why?
Hematopoiesis
1
2020
166
0.040
Why?
Gene Expression
2
2015
1310
0.040
Why?
Blood Platelets
1
2019
150
0.040
Why?
Histone Deacetylase Inhibitors
1
2018
92
0.040
Why?
Retreatment
1
2017
108
0.040
Why?
Proto-Oncogene Proteins
1
2021
665
0.040
Why?
Internationality
1
2017
69
0.040
Why?
Single-Blind Method
1
2017
150
0.040
Why?
BCG Vaccine
1
2017
35
0.040
Why?
Amino Acid Substitution
1
2018
338
0.040
Why?
Remission Induction
1
2018
740
0.030
Why?
DNA Mutational Analysis
1
2018
529
0.030
Why?
National Institutes of Health (U.S.)
1
2017
125
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
78
0.030
Why?
Immunoglobulins, Intravenous
1
2016
65
0.030
Why?
Receptors, Antigen, T-Cell
1
2018
394
0.030
Why?
Cholesterol, Dietary
1
2015
27
0.030
Why?
Transplants
1
2016
41
0.030
Why?
E-Selectin
1
2015
30
0.030
Why?
Carotid Artery Injuries
1
2015
22
0.030
Why?
Chemotaxis, Leukocyte
1
2015
38
0.030
Why?
Glycoside Hydrolase Inhibitors
1
2015
1
0.030
Why?
1-Deoxynojirimycin
1
2015
3
0.030
Why?
Receptors, LDL
1
2015
55
0.030
Why?
RNA Polymerase II
1
2015
57
0.030
Why?
Netrin Receptors
1
2014
7
0.030
Why?
Protein Interaction Mapping
1
2015
82
0.030
Why?
Hyperglycemia
1
2016
172
0.030
Why?
Primary Cell Culture
1
2015
76
0.030
Why?
Lentivirus
1
2015
43
0.030
Why?
Administration, Oral
1
2016
682
0.030
Why?
Transplant Recipients
1
2016
137
0.030
Why?
Microsomes, Liver
1
2014
49
0.030
Why?
Transduction, Genetic
1
2015
160
0.030
Why?
Transgenes
1
2015
185
0.030
Why?
Recurrence
2
2011
1144
0.030
Why?
Plasmids
1
2015
291
0.030
Why?
Reference Standards
1
2014
144
0.030
Why?
Ireland
1
2013
9
0.030
Why?
Cluster Analysis
1
2014
371
0.030
Why?
Societies, Medical
1
2017
575
0.030
Why?
Nephrectomy
1
2016
295
0.030
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
172
0.030
Why?
Genetic Vectors
1
2015
446
0.030
Why?
Multicenter Studies as Topic
1
2013
155
0.030
Why?
Transplantation Chimera
1
2012
81
0.030
Why?
Endothelial Cells
1
2015
460
0.030
Why?
United States Department of Defense
1
2011
5
0.030
Why?
Graft Survival
1
2016
900
0.020
Why?
Early Termination of Clinical Trials
1
2011
16
0.020
Why?
Retrospective Studies
2
2018
9057
0.020
Why?
Promoter Regions, Genetic
1
2015
956
0.020
Why?
Immunohistochemistry
1
2016
1799
0.020
Why?
Students
1
2013
170
0.020
Why?
Nerve Tissue Proteins
1
2015
511
0.020
Why?
Orchiectomy
1
2011
72
0.020
Why?
Transplantation, Autologous
2
2003
344
0.020
Why?
Contrast Media
1
2016
1091
0.020
Why?
Computational Biology
1
2014
543
0.020
Why?
Action Potentials
1
2015
600
0.020
Why?
Insulin
1
2016
1146
0.020
Why?
Genes, X-Linked
1
2011
38
0.020
Why?
Diarrhea
1
2011
182
0.020
Why?
Transcription, Genetic
1
2015
1157
0.020
Why?
Proportional Hazards Models
1
2012
851
0.020
Why?
Mice, Knockout
1
2015
2001
0.020
Why?
Patient Compliance
1
2011
231
0.020
Why?
Cells, Cultured
1
2015
2884
0.020
Why?
Lymphoma, Non-Hodgkin
1
2011
261
0.020
Why?
Herpesvirus 4, Human
1
2010
119
0.020
Why?
Quality Improvement
1
2013
451
0.020
Why?
Adenosine Triphosphate
1
2010
316
0.020
Why?
Laparoscopy
1
2016
773
0.020
Why?
Registries
1
2013
784
0.020
Why?
Severity of Illness Index
1
2014
1840
0.020
Why?
Cell Differentiation
1
2015
1525
0.020
Why?
Mice, Inbred C57BL
1
2015
3218
0.020
Why?
Neoplasm Proteins
1
2011
540
0.020
Why?
Diabetes Mellitus, Type 2
1
2016
1176
0.020
Why?
Transcription Factors
1
2015
1653
0.020
Why?
Child
2
2012
7174
0.020
Why?
Physicians
1
2013
690
0.020
Why?
Gene Expression Profiling
1
2011
1431
0.020
Why?
Leukemia, Myeloid, Acute
1
2011
793
0.020
Why?
Biomarkers
1
2011
1767
0.010
Why?
Baltimore
1
2001
40
0.010
Why?
Mice
1
2015
11761
0.010
Why?
Longitudinal Studies
1
2001
1072
0.010
Why?
Animals
1
2015
27371
0.010
Why?
O'Donnell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (446)
Explore
_
Co-Authors (94)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_